2021/8/7-8 

Welcome Address                                                      Distinguished Guest

Keynote Lecture(I) Unmet need of HBV management                  Functional cure of hepatitis B

Basic studies of HBV                                                           New advance in HBV and HCV coinfection

Keynote Lecture(II) Toward global HCV elimination          Extrahepatic manifestation after HCV cure

Gap toward HCV elimination                                     Unmet need of medical Treatment of HCV infection

Oral Presentation

Closing Remarks & Welcome Address                         MAFLD:New Concept and Clinical Implications

Advance in the pathology of metabolic fatty liver disease

Keynote Lecture(III)

Leveraging Energy Expenditure in the Management of Non-Alcoholic Fatty Liver Disease

Keynote Lecture(IV)

Impact of dietary fat on the steatosis-associated liver tumorigenesis

Update of systemic therapy for HCC

Emerging advance of immunotherapy-based strategy for HCC

Efficacy of target and immunotherapy among different etiologies of aHCC

Gut microbiota and NAFLD/NASH

Closing Remarks

全體工作人員合照